Company / Debt per Share
NovoCure Ltd Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$1.80
FY2025
5-year range
$0.91 / $5.49
FY2021-FY2025
Trend
+97.8%
vs FY2024
Sector context
#87 of 100
Health Care
What the data says
NovoCure Ltd's debt per share of $1.80 is lower than 87% of companies in the Health Care sector (FY2025). Debt per Share returned to growth in FY2025 after 3 years of decline, reaching $1.80.
Based on SEC 10-K filings.
1.80 in FY2025 with a 5-year CAGR of -16.1%.
Improved from $5.41 to $1.80 over the past 2 years.
Health Care sector context is included.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -30.9%
- 5-Year CAGR
- -16.1%
- 10-Year CAGR
- -
Sector benchmark
Top 13% in Health CareTop 13% of 100This company $1.80 Sector average $45.62
▼
-96.1% below sector average
Key checks
Key Insights
- In FY2025, debt per share increased 97.8% year-over-year.
- Ranks #87 out of 100 companies in the Health Care sector.
- Peak debt per share was recorded in FY2021.
- Lowest debt per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.80 | +97.8% |
| FY2024 | $0.91 | -83.2% |
| FY2023 | $5.41 | -0.4% |
| FY2022 | $5.44 | -1.0% |
| FY2021 | $5.49 | +27.2% |
| FY2020 | $4.32 | +169.6% |
| FY2019 | $1.60 | -3.9% |
| FY2018 | $1.67 | +49.2% |
| FY2017 | $1.12 | -2.7% |
| FY2016 | $1.15 | -33.2% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026